Remove 2028 Remove Communication Remove Pharmaceutical Companies
article thumbnail

Growing pains: how the pharmaceutical industry can hire and retain talent during industry boom

pharmaphorum

Recruiting and retaining talent is one of the biggest challenges facing the industry now through 2028, as the US Bureau of Labor Statistics expects life, physical, and social sciences to grow 7%. Paired with the current US pharmaceutical job vacancy rate of around 8%, companies will need to pivot to fill the incredible labour needs.

article thumbnail

The EU joint HTA procedure: a gate or barrier for access?

Pharmaceutical Technology

The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. Will the joint procedure drive positive change? Please check your email to download the Case Study.

article thumbnail

RFK Jr axes vaccine advisory committee members

Pharmaceutical Technology

Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies.